ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 фев 2024 19:01:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

04 янв 2024 16:40:44 Источник Nasdaq GlobeNewswire

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 дек 2023 18:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

29 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

09 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference

08 ноя 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

02 ноя 2023 09:05:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

23 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting

13 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

02 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

25 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference

20 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

11 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates

06 сен 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation

16 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results

10 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference

02 июн 2023 08:00:00 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results

11 май 2023 16:01:01 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

04 май 2023 16:05:03 Источник Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials

01 май 2023 07:00:00 Источник Nasdaq GlobeNewswire